Search results
Results from the WOW.Com Content Network
Triamcinolone acetonide, sold under the brand name Kenalog among others, is a synthetic corticosteroid medication used topically to treat various skin conditions, [13] to relieve the discomfort of mouth sores, and by injection into joints to treat various joint conditions.
Triamcinolone is used to treat many different medical conditions, such as eczema, alopecia areata, lichen sclerosus, psoriasis, arthritis, allergies, ulcerative colitis, lupus, sympathetic ophthalmia, temporal arteritis, uveitis, ocular inflammation, keloids, urushiol-induced contact dermatitis, aphthous ulcers (usually as triamcinolone acetonide), central retinal vein occlusion, visualization ...
One clinical trial comparing Debacterol to Kenalog-in-Orabase and a no-intervention control group found that patients treated with sulfonated phenolics/sulfuric acid reported significantly better relief of symptoms compared to the other two groups three days after treatment. [4]
Novo Nordisk said it expects results from a second Phase 3 trial of the medicine, this one in people with type 2 diabetes, in the first half of 2025. The study reported Friday, which Novo Nordisk ...
See today's average mortgage rates for a 30-year fixed mortgage, 15-year fixed, jumbo loans, refinance rates and more — including up-to-date rate news.
At the long-awaited trial, the jury found the accused guilty of all the charges brought against him, including one count of murder with special circumstance allegations as the crime was committed ...
Triamcinolone hexacetonide; Clinical data; Trade names: Aristospan: Other names: Triamcinolone acetonide 21-tebutate; Triamcinolone acetonide 21-(tert-butylacetate ...
The Food and Drug Administration approved Lynparza in 2022 based on primary trial results published in the New England Journal of Medicine in 2021. The drug, according to Merck, is the first and ...